Immix Biopharma, Inc.
IMMX
$10.97
$0.050.46%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 7.12M | 4.82M | 5.17M | 3.08M | 2.75M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.46M | 10.80M | 10.89M | 7.66M | 6.72M |
| Operating Income | -12.46M | -10.80M | -10.89M | -7.66M | -6.72M |
| Income Before Tax | -11.54M | -10.09M | -10.68M | -7.58M | -6.61M |
| Income Tax Expenses | 14.30K | -- | 11.30K | 7.70K | 8.90K |
| Earnings from Continuing Operations | -11.56M | -10.09M | -10.69M | -7.59M | -6.62M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.56M | -10.09M | -10.69M | -7.59M | -6.62M |
| EBIT | -12.46M | -10.80M | -10.89M | -7.66M | -6.72M |
| EBITDA | -12.37M | -10.71M | -10.84M | -7.57M | -6.66M |
| EPS Basic | -0.18 | -0.18 | -0.27 | -0.24 | -0.22 |
| Normalized Basic EPS | -0.11 | -0.11 | -0.17 | -0.15 | -0.14 |
| EPS Diluted | -0.18 | -0.18 | -0.27 | -0.24 | -0.22 |
| Normalized Diluted EPS | -0.11 | -0.11 | -0.17 | -0.15 | -0.14 |
| Average Basic Shares Outstanding | 63.77M | 55.37M | 40.22M | 31.93M | 29.98M |
| Average Diluted Shares Outstanding | 63.77M | 55.37M | 40.22M | 31.93M | 29.98M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |